Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Cheung
    Cheung
  2. Modak
    Modak
  3. Kushner
    Kushner
  4. Basu
    Basu
  5. Hadjantonakis
    Hadjantonakis
  6. Mauguen
    Mauguen
  7. Wolden
    Wolden
  8. Cheung
    Cheung
  9. O'Reilly
    O'Reilly
  10. Curran
    Curran

Groups

  1. Center for Molecular Imaging and Biotechnology (55)
  2. GSK Faculty (55)
  3. Tow Center for Developmental Oncology (TCDO) (48)
  4. Pediatrics, Department of (42)
  5. Neuroblastoma Service (38)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)
  7. Sloan Kettering Institute Postdocs (17)
  8. Center for Hematologic Malignancies (16)
  9. Sloan Kettering Institute Faculty (14)
  10. Epidemiology and Biostatistics (13)
Search Within
  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (21)
  3. Review (2)
Groups
  1. Center for Molecular Imaging and Biotechnology (55)
  2. GSK Faculty (55)
  3. Tow Center for Developmental Oncology (TCDO) (48)
  4. Pediatrics, Department of (42)
  5. Neuroblastoma Service (38)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)

More Groups

People
  1. Nai-Kong Cheung (36)
  2. Shakeel Modak (22)
  3. Brian Kushner (21)
  4. Stephen Roberts (15)
  5. Ellen Basu (14)
  6. Anna-Katerina Hadjantonakis (5)

More People

Years
  1. 2022 (4)
  2. 2021 (4)
  3. 2020 (3)
  4. 2019 (10)
  5. 2018 (5)
  6. 2017 (2)

More Years

Publications
  1. Pediatric Blood and Cancer (41)
  2. Genes Chromosomes and Cancer (6)
  3. Developmental Dynamics (3)
  4. Wiley Interdisciplinary Reviews: Developmental Biology (3)
  5. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (1)
  6. Wiley Interdisciplinary Reviews: RNA (1)

Results (55)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Favorable toxicity profile of bivalent GD2/GD3 neuroblastoma vaccine
    Meeting Abstract

    Modak, S.; Cheung, N. K.; Basu, E.; Roberts, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
    Journal Article

    Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save